Medicine
Vizz 14.66 mg/mL eye drops
Vizz 14.66 mg/mL eye drops is a prescription medicine containing Aceclidine for ophthalmic use, marketed by LENZ Therapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store refrigerated at 36°F to 46°F (2°C to 8°C). Do not freeze. When stored in…
Key facts
- Active ingredient (INN)
- Aceclidine
- Brand
- Vizz
- Strength
- 14.66 mg/mL
- Dosage form
- Eye drops
- Route
- Ophthalmic
- Packs
- 5 pouches
- Marketing authorisation holder
- LENZ Therapeutics
- Manufacturer
- LENZ Therapeutics
- Origin register
- US FDA, United States
- Storage
- Store refrigerated at 36°F to 46°F (2°C to 8°C). Do not freeze. When stored in refrigerated conditions, VIZZ can be used until the expiration date. Once pouch or vial(s) are removed from refrigeration, VIZZ may be stored at room temperature [up to 77°F (25°C)] but must be used within 30 days.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- S01EB08 Aceclidine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 July 2025
- Identifiers
- RxCUI 2721771, 2721776DailyMed set ID 7aed8024-ad30-44d6-8f3b-63338ad3ce52NDC 84226-100Application NDA218585
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 pouch in 1 carton / 5 ampule in 1 pouch / .4 mL in 1 ampule | 84226-100-11 | LENZ Therapeutics | 31 July 2025 |
| 5 pouch in 1 carton / 5 ampule in 1 pouch / .25 mL in 1 ampule | 84226-100-21 | LENZ Therapeutics | 2 January 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 31 July 2025 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Aceclidine is a cholinergic receptor agonist indicated for the treatment of presbyopia in adults. It is available as eye drops for ophthalmic use. MedsAcross supplies Aceclidine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AceclidineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- VIZZ prescribing information (LENZ Therapeutics) · U.S. National Library of Medicine, DailyMed
Need Vizz 14.66 mg/mL eye drops for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.